Zhejiang Gongdong Medical Technology Management
Management criteria checks 3/4
Zhejiang Gongdong Medical Technology's CEO is Weifeng Zhong, appointed in Oct 2017, has a tenure of 7.25 years. directly owns 0.77% of the company’s shares, worth CN¥33.64M. The average tenure of the management team and the board of directors is 7.3 years and 7.3 years respectively.
Key information
Weifeng Zhong
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.3yrs |
| CEO ownership | 0.8% |
| Management average tenure | 7.3yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
CEO
Weifeng Zhong (47 yo)
7.3yrs
Tenure
CN¥541,400
Compensation
Mr. Weifeng Zhong has been General Manager and Director of Zhejiang Gongdong Medical Technology Co.,Ltd. since October 2017.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 7.3yrs | CN¥541.40k | 0.77% CN¥ 33.6m | |
| Deputy GM & Director | 7.3yrs | CN¥370.50k | no data | |
| Board Secretary & Director | 7.3yrs | CN¥443.90k | 0.021% CN¥ 908.4k | |
| Deputy General Manager | 7.3yrs | CN¥443.80k | 0.012% CN¥ 526.0k |
7.3yrs
Average Tenure
51.5yo
Average Age
Experienced Management: 605369's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 7.3yrs | CN¥541.40k | 0.77% CN¥ 33.6m | |
| Deputy GM & Director | 7.3yrs | CN¥370.50k | no data | |
| Board Secretary & Director | 7.3yrs | CN¥443.90k | 0.021% CN¥ 908.4k | |
| Chairman | 7.3yrs | CN¥635.90k | 64.94% CN¥ 2.8b | |
| Chairman of the Supervisory Board | 7.3yrs | no data | no data | |
| Employee Representative Supervisor | 7.3yrs | no data | no data | |
| Supervisor | 7.3yrs | no data | no data |
7.3yrs
Average Tenure
47yo
Average Age
Experienced Board: 605369's board of directors are considered experienced (7.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 07:33 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Gongdong Medical Technology Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuo Song | Citic Securities Co., Ltd. |
| Siyu Peng | Guosen Securities Co., Ltd. |
| Muqing Xie | Zhongtai Securities Co. Ltd. |